한희동 (프레스티지 바이오파마 코리아)님 | 한빛사연구자 > 한빛사

프레스티지 바이오파마 코리아

최종업데이트 2022.09.05.

Enhancement of anticancer immunity by immunomodulation of apoptotic tumor cells using annexin A5 protein-labeled nanocarrier system
- Biomaterials, Volume 288, September 2022, 121677 | https://doi.org/10.1016/j.biomaterials.2022.121677
- 2022-09
- 의약학
- 한빛사논문
Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches
- J. Immunother. Cancer, First published February 28, 2022 | http://dx.doi.org/10.1136/jitc-2021-003928
- 2022-02
- 바이오·의료융합
- 한빛사논문
Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma
- Mol. Cancer Ther., 15(4); 618–27. | DOI: 10.1158/1535-7163.MCT-15-0733-T
- 2016-04
- 의약학
- 구.추천논문
- 한희동(U.T. M.D. Anderson Cancer Center)
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
- Clin. Cancer Res., Published OnlineFirst June 10, 2010; doi: 10.1158/1078-0432.CCR-10-0005
- 2010-08
- 바이오·의료융합
- 상위피인용논문
- 한희동(U.T. M.D. Anderson Cancer Center)
  Interview
Regulation of Tumor Angiogenesis by EZH2
- Cancer Cell, Volume 18, Issue 2, 185-197, 17 August 2010 | DOI 10.1016/j.ccr.2010.06.016
- 2010-08
- 바이오·의료융합
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문